Search Results

Creating data is easy. The rapid analysis and use of that data, however, is orders of magnitude more difficult. Biopharma companies are under pressure from all sides to leverage the power of data analytics. Financial stakeholders expect a timely return on their investment. Regulators are closely scrutinizing the biopharma industry as it explores new...

Traditional approaches for making, testing and deciding which new materials need to be replaced by a holistic digital solution Materials scientists today can engineer complex nanostructures and model topologically intricate architectures with relative ease. But unlike in other fields, they can’t seem to shed antiquated workflows and outmoded data storage and...

We recently launched Signals Image Artist™ the fast, efficient image analysis and data management solution for High Content Screening and cellular image data that integrates with Revvity Signals Signals™ VitroVivo for secondary data analysis. High Content Screening is a mainstream technology for drug research. More and more experiments are run on more and...

Blog: Clinical and Translational This practice is lab- and data-driven, aspiring to make a bench-to-bedside approach that’ll efficiently develop therapeutic strategies. It identifies biomarkers that can then be used to inform the patient’s molecular profiles and disease etiologies. Biomarkers can include blood sugar levels that identify patients with...

Market leading innovator in laboratory digital transformation, Scitara, has announced a collaboration with scientific analytical technology leader, Revvity Signals. The move will support the integration of the Revvity Signals Research Suite™ informatics platform, which provides seamless, end-to-end scientific data and workflow management, with laboratory...